Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Margaret Block"'
Autor:
Costanza Paoletti, Meredith M. Regan, Samuel M. Niman, Emily M. Dolce, Elizabeth P. Darga, Minetta C. Liu, P. Kelly Marcom, Lowell L. Hart, John W. Smith, Karen L. Tedesco, Eitan Amir, Ian E. Krop, Angela M. DeMichele, Pamela J. Goodwin, Margaret Block, Kimberly Aung, Martha E. Brown, Robert T. McCormack, Daniel F. Hayes
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-9 (2021)
Abstract Circulating tumor cells (CTC) are prognostic in metastatic breast cancer (MBC). The CTC-endocrine therapy index (CTC-ETI), consisting of CTC-ER (estrogen receptor), BCL2, human epidermal growth factor receptor (HER2), and Ki67 expression, mi
Externí odkaz:
https://doaj.org/article/a4591a6d3a9d4069a97a9133183bb04c
Autor:
Karen L Smith, Fengmin Zhao, Ingrid A Mayer, Amye J Tevaarwerk, Sofia F Garcia, Carlos L Arteaga, William F Symmans, Ben H Park, Brian L Burnette, Della F Makower, Margaret Block, Kimberly A Morley, Chirag R Jani, Craig Mescher, Shabana J Dewani, Ursa Brown-Glaberman, Lisa E Flaum, Erica L Mayer, William M Sikov, Eve T Rodler, Angela M DeMichele, Joseph A Sparano, Antonio C Wolff, Kathy D Miller, Lynne I Wagner
Publikováno v:
Cancer Research. 82:P4-10
Background: Understanding health-related quality of life (HRQOL), including side effects, is critical to guide supportive care during chemotherapy. The EA1131 trial demonstrated that Platinum (Plat) was unlikely to improve outcomes compared to capeci
Autor:
Karen L. Smith, Bernard Tawfik, William Fraser Symmans, Kathy D. Miller, Erica L. Mayer, Ingrid A. Mayer, Margaret Block, Angela DeMichele, Shabana Jaynul Dewani, Amye J. Tevaarwerk, Carlos L. Arteaga, Lisa Flaum, Della F. Makower, Craig Mescher, Chirag Jani, Joseph A. Sparano, Lynne I. Wagner, Fengmin Zhao, William M. Sikov, Eve T. Rodler, Ben Ho Park, Kimberly A. Morley, Brian L. Burnette, Antonio C. Wolff, Sofia F. Garcia
Publikováno v:
Journal of Clinical Oncology. 39:3522-3524
Autor:
Margaret Block, Michael A. Danso, Tracy Locke, Joyce O'Shaughnessy, William Fintel, Nicholas Koutrelakos, Ling Ma, David Andorsky, Yunfei Wang, Kristi McIntyre, Amy Scales, Sharon Wilks, Lauren Steckel
Publikováno v:
Cancer Research. 80:PD7-10
Elevated expression of AURKA adversely affects prognosis in ER+ breast cancer and is associated with resistance to taxanes, endocrine therapy, and PI3K inhibitors. A recent randomized phase II trial of combined paclitaxel plus alisertib (P+A) in recu
Autor:
Sramila Aithal, Hendrik Tobias Arkenau, Muriel Siadak, Erica Stringer-Reasor, Mathilde Cancel, Erik Jakobsen, Erika Hamilton, Eva Harder Brix, Marco Colleoni, Cristiano Ferrario, Volkmar Mueller, Elisavet Paplomata, Amelia Zelnak, Frances M. Boyle, Elsa Curtit, S. Cold, Kendra DeBusk, Wentao Feng, Karen A. Gelmon, Margaret Block, Laurence Crouzet, Montserrat Muñoz-Mateu, Giuseppe Curigliano, Olwen Hahn, David Cameron, Andrew M Wardley, Nayyer Iqbal, Jorge Ramos, Teja Poosarla, Louis Fehrenbacher, Andrew Brenner
Publikováno v:
Mueller, V, Wardley, A, Paplomata, E, Hamilton, E, Zelnak, A, Fehrenbacher, L, Jakobsen, E, Curtit, E, Boyle, F, Harder Brix, E, Brenner, A, Crouzet, L, Ferrario, C, Muñoz-Mateu, M, Arkenau, H T, Iqbal, N, Aithal, S, Block, M, Cold, S, Cancel, M, Hahn, O, Poosarla, T, Stringer-Reasor, E, Colleoni, M, Cameron, D, Curigliano, G, Siadak, M, DeBusk, K, Ramos, J, Feng, W & Gelmon, K 2021, ' Preservation of quality of life in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial) ', European Journal of Cancer, vol. 153, pp. 223-233 . https://doi.org/10.1016/j.ejca.2021.05.025
Aims: In HER2CLIMB, tucatinib significantly improved progression-free and overall survival in patients with human epidermal growth factor receptor 2–positive (HER2+) metastatic breast cancer. We evaluated the impact of tucatinib on health-related q
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7721317814dc77c16d150d44866186d
https://findresearcher.sdu.dk:8443/ws/files/184128629/Open_Access_Version.pdf
https://findresearcher.sdu.dk:8443/ws/files/184128629/Open_Access_Version.pdf
Autor:
Martha E. Brown, Ian E. Krop, Eitan Amir, Margaret Block, Kimberly Aung, Karen L. Tedesco, Elizabeth P. Darga, Angela DeMichele, Meredith M. Regan, Costanza Paoletti, John W. Smith, Robert T. McCormack, Samuel M. Niman, Lowell L. Hart, Minetta C. Liu, Emily M. Dolce, Daniel F. Hayes, Pamela J. Goodwin, P. Kelly Marcom
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-9 (2021)
NPJ Breast Cancer
NPJ Breast Cancer
Circulating tumor cells (CTC) are prognostic in metastatic breast cancer (MBC). The CTC-endocrine therapy index (CTC-ETI), consisting of CTC-ER (estrogen receptor), BCL2, human epidermal growth factor receptor (HER2), and Ki67 expression, might predi
Autor:
Carlos L. Arteaga, Margaret Block, Shabana Jaynul Dewani, Lisa Flaum, William Fraser Symmans, Angela DeMichele, Chirag Jani, Karen L. Smith, Amye J. Tevaarwerk, Erica L. Mayer, Fengmin Zhao, Bernard Tawfik, Eve T. Rodler, Della F. Makower, Lynne I. Wagner, Kathy D. Miller, Joseph A. Sparano, Craig Mescher, Kimberly A. Morley, Sofia F. Garcia, William M. Sikov, Ben Ho Park, Ingrid A. Mayer, Brian L. Burnette, Antonio C. Wolff
Publikováno v:
J Clin Oncol
PURPOSE Patients with triple-negative breast cancer (TNBC) and residual invasive disease (RD) after completion of neoadjuvant chemotherapy (NAC) have a high-risk for recurrence, which is reduced by adjuvant capecitabine. Preclinical models support th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c662aa16b723441992e414909d49913c
https://europepmc.org/articles/PMC8577688/
https://europepmc.org/articles/PMC8577688/
Autor:
Teja Poosarla, Andrew M Wardley, Jorge Ramos, Karen A. Gelmon, Marie-Agnes By, Volkmar Mueller, Marco Colleoni, Giuseppe Curigliano, Sramila Aithal, Xuebei An, David Cameron, Erica Stringer-Reasor, Nayyer Iqbal, Søren Cold, Kendra DeBusk, Margaret Block, Laurence Crouzet, Elisavet Paplomata, Olwen Hahn, Muriel Siadak
Publikováno v:
Cancer Research. 81:PD13-04
Background Patients (pts) with human epidermal growth factor receptor 2 positive (HER2+) metastatic breast cancer (MBC) who have brain metastases (BM) have limited treatment options and lower health-related quality of life (HRQoL) compared with pts w
Autor:
Ernest DiNino, Mark Tidswell, Garry Schwartz, Nura El-Haj, Margaret Block, Nimish Shah, James Wall, Jonathan M. Davis
Publikováno v:
Transfusion. 58:132-137
BACKGROUND Red blood cell (RBC) transfusion is an important treatment modality during severe sickle cell crisis (SCC). SCC patients who refuse, or cannot accept, RBCs present a unique challenge. Acellular hemoglobin (Hb)-based oxygen carriers (HBOCs)
Autor:
Amy Scales, Sharon Wilks, Ling Ma, Tracy Locke, Kristi McIntyre, Yunfei Wang, Michael A. Danso, David Andorsky, Joyce O'Shaughnessy, Margaret Block
Publikováno v:
JAMA Netw Open
Importance Elevated expression of AURKA adversely affects prognosis in estrogen receptor (ER)-positive and ERBB2 (formerly HER2)-negative and triple-negative breast cancer and is associated with resistance to taxanes. Objective To compare paclitaxel